Nurse Practitioner, Family · Shenandoah, TX
NPI
1710521422
Since 2019
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
3
Medicare group memberships
Hospitals
3
Hospital affiliations
129 Vision Park Blvd Ste 109
Shenandoah, TX, 77384
Phone (936) 273-0836
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,519
175 services
Medicare patients, 2024
33
Average age 75
Drug cost, 2024
$438K
725 prescriptions
Company payments, 2025
$1,058
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jamie Faust was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 19 times for 16 patients. In total Jamie Faust billed 175 services in 9 codes, and Medicare paid $5,519.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-16.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 19 | 16 | $11.00 | $209 |
By year: 2022 $27K for 482 services; 2023 $3,389 for 125 services; 2024 $5,519 for 175 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jamie Faust prescribed most often to Medicare patients was Xphozah (Tenapanor Hcl), with 105 prescriptions and refills. In total Jamie Faust wrote 725 Medicare prescriptions that cost $438K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xphozah Tenapanor Hcl | 105 | 111 | 21 | $314K |
| Midodrine Hcl Generic | 49 | 107 | 18 | $8,054 |
| Furosemide Generic | 41 | 113 | 22 | $428 |
| Nifedipine Er Nifedipine | 40 | 109 | 18 | $1,574 |
| Sevelamer Carbonate Generic | 36 | 80 | 17 | $11K |
| Calcium Acetate Generic | 28 | 73 | 12 | $3,490 |
| Carvedilol Generic | 27 | 77 | 12 | $290 |
| Amlodipine Besylate Generic | 26 | 72 | 11 | $84.33 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 21 | 36 | Under 11 | $550 |
| Metoprolol Tartrate Generic | 20 | 38 | Under 11 | $157 |
| Losartan Potassium Generic | 19 | 51 | Under 11 | $294 |
| Gabapentin Generic | 17 | 51 | Under 11 | $371 |
| Bumetanide Generic | 16 | 40 | Under 11 | $2,047 |
| Hydralazine Hcl Generic | 15 | 37 | Under 11 | $361 |
| Atorvastatin Calcium Generic | 14 | 38 | Under 11 | $103 |
Brand drugs: 160 claims; generic drugs: 565 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jamie Faust $1,058 ($1,058 in general payments such as food, travel and fees) from 14 companies. The largest payer was Calliditas Therapeutics US Inc. with $221.
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 7 | $221 |
| Ardelyx, Inc. ARDX | 4 | $183 |
| Kyowa Kirin, Inc. 4151.T | 4 | $176 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $89.27 |
| Scpharmaceuticals Inc. SCPH | 3 | $60.46 |
| Lilly USA, LLC LLY | 3 | $52.09 |
| Amgen Inc. AMGN | 2 | $51.18 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $46.4 |
| Akebia Therapeutics Inc AKBA | 2 | $41.41 |
| Renalytix AI, Inc. | 2 | $39.25 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.